$7.35
0.000.00%
Pre-Market: 4:00 PM EDT
EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-05 | $-0.64 | $-0.48 | -33.3 % |
Q3 | 2024-11-07 | $-0.54 | $-0.55 | 1.82 % |
Q2 | 2024-08-07 | $-0.58 | $-0.52 | -11.5 % |
Q1 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-05 | $11.59M | $11.02M | 5.15 % |
Q3 | 2024-11-07 | $10.52M | $9.93M | 5.98 % |
Q2 | 2024-08-07 | $9.48M | $9.59M | -1.18 % |
Q1 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
The Actual EPS was $-0.64, which missed the estimate of $-0.48.
The Actual Revenue was $11.6M, which beat the estimate of $11M.
Browse earnings estimates, EPS, and revenue on all stocks.